Search

everythinglearnresearchcommunity

for

Search:↓

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Early diagnosis and genetic counseling are crucial for managing adrenoleukodystrophy.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Upadacitinib may cause hair loss.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Men with Addison disease should be screened for X-linked adrenoleukodystrophy if they have hair loss.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Two brothers from Bangladesh were diagnosed with X-linked adrenoleukodystrophy, showing neurological and adrenal symptoms.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

AHR ligands could treat inflammatory skin diseases.

Microemulsions improve adapalene's skin absorption for better acne treatment.

Alopecia areata progression is linked to stress and hormone changes, suggesting new treatment targets.

Higher CRHR1 levels in AA patients lead to increased inflammation.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.